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Treatment of obstructive sleep apnea patients using oral appliances –
our experiences
Leþenje opstruktivne apneje u snu pomoüu oralnih aparata – naša iskustva
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Department for Prosthodontics, Faculty of Dentistry, University of Belgrade, Belgrade,
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Abstract
Background/Aim. Obstructive sleep apnea (OSA) is one
of the most prevalent sleep disorders. It is recognized as a
serious risk factor for car and workplace accidents due to
daytime sleepiness, and factor for coronary heart diseases
and stroke. The aim of this study was to examine the ef-
fectiveness of oral appliances for mandibular advance in
treating mild to moderate OSA. Methods. A total of 15
patients were included in this study, all diagnosed with
mild or moderate OSA. Oral appliances were custom
made for each patient in protrusive position at 50% of
maximum mandibular advancement. The patients were
given instructions not to sleep on their backs and avoid al-
cohol consumption during the study as these are the fac-
tors that can contribute to symptoms progression. Re-
sults. Complete and partial treatment success was achieve
in 14 of the patients. Apnea-hypopnea index values were
significantly lower (p < 0.05) at the end of a 6-month ob-
servation period compared to those at the treatment be-
ginning. A great improvement in symptoms was observed,
with daytime sleepiness index values significantly reduced
already within the first month of the treatment. Conclu-
sion. Treatment of obstructive sleep apnea with oral ap-
pliances has proven successful. Patients were comfortable
using oral appliances and were ready to wear them for
prolonged period of time. Use of oral appliances is very
common in the world and should not be discarded. They
are also very comfortable, practical and affordable com-
paring to continuous positive airway pressure (CPAP) ap-
paratus, not to mention surgery. Use of oral appliances is
safe and very well tolerated, and ought to be offered to
patients with OSA.
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Apstrakt
Uvod/Cilj. Opstruktivna apneja u snu je jedan od najÿešýih
poremeýaja spavanja. Dokazano je da su bolesnici koji pate
od ovog poremeýaja skloniji saobraýajnim nezgodama i po-
vredama na radu, kao i da su izloženi veýem riziku od nas-
tanka koronarne bolesti srca i moždanog udara. Cilj ovog
istraživanja bio je da se utvrdi uspešnost terapije blage i
umerene opstruktivne apneje u snu oralnim aparatima.
Metode. Ukupno 15 bolesnika sa prethodno uspostavlje-
nom dijagnozom blage ili umerene opstruktivne apneje u
snu bilo je ukljuÿeno u istraživanje. Oralni aparati su indivi-
dualno uraĀeni za svakog bolesnika, sa mandibulom u prot-
ruzionom položaju 50% od maksimalnog. Bolesnicima je
preporuÿeno da izbegavaju spavanje na leĀima i unošenje
alkohola tokom trajanja studije, jer ovi faktori mogu uticati
na pogoršanje simptoma. Rezultati. Potpuni i delimiÿni us-
peh terapije postignut je kod 14 bolesnika. Vrednosti apne-
ja-hipopneja indeksa bile su statistiÿki znaÿajno niže
(p < 0,05) od poÿetnih vrednosti na kraju 6-meseÿnog peri-
oda posmatranja. Registrovano je i znaÿajno poboljšanje
simptoma, kao i znaÿajno umanjenje vretnosti indeksa dne-
vne pospanosti veý posle prvog meseca terapije. Zakljuÿak.
Oralni aparati su bili uspešni u leÿenju opstruktivne apneje u
snu. Bolesnici su iskazali veliku lagodnost i bili su spremni
da nose oralne aparate i duži vremenski period. Upotreba
oralnih aparata je uobiÿajena u svetu, i ne treba da bude za-
nemarena. Vrlo su praktiÿni, lagodni za nošenje i pristupaÿ-
niji u poreĀenju sa aparatom za kontinuirani pozitivni priti-
sak u disajnim putevima (CPAP), a pogotovo sa hirurškom
intervencijom. Upotreba oralnih aparata je bezbedna i tre-
balo bi je ponuditi bolesnicima kao jedno od moguýih reše-
nja.
Kljuÿne reÿi:
apneja u snu, opstruktivna; ortodontski aparati;
leÿenje, ishod.
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Introduction
One third of human life is spent sleeping, so the need
for a healthy and undisturbed night sleep is of essence. There
are many sleep disorders described so far 1, obstructive sleep
apnea (OSA) being one of the most common, affecting at
least 1–5% of adult population 2, 3. Due to structurally small
or highly collapsible upper airways, patients suffer from ab-
normal ventilation during sleep, manifesting in a complete or
partial blockade of breathing, repeatedly during the night.
Fragmented sleep affects daytime concentration and presents
significant problem for the patients. It is described that peo-
ple suffering from OSA are prone to work place accidents,
and more often involved in car crashes due to overt sleep and
inattention due to sleepiness 4, 5. OSA is recognized as a seri-
ous risk factor for hypertension, coronary heart disease and
stroke 6–8, and as such, it needs to be properly diagnosed and
treated accordingly. In addition, patients are not well edu-
cated and informed about symptoms and risks of obstructive
sleep apnea, and are not aware that they suffer from this seri-
ous condition. Furthermore, patients who are diagnosed are
mainly offered only continuous positive airway pressure
(CPAP). CPAP is the use of continuous positive pressure to
maintain a continuous level of positive airway pressure but
apparatus used for this is highly uncomfortable and patients
can not adequately adjust 9. Another treatment modality for
OSA patients is surgery but, as all surgery options, it repre-
sents a risk for patients, and thus, alternative treatments that
are safe, effective, and acceptable are needed.
Oral appliances for mandibular advance are used for
treating mild and moderate OSA, and are proved very suc-
cessful 10–12. In addition, patients reported high levels of
comfort, and were prepared to use oral appliances for longer
period of time 12. Varieties of oral appliances are used for
treating OSA, and are all quite effective 13. It is important to
present oral appliances for mandibular advance as treatment
modality to both patients suffering from OSA and medical
practitioners treating them.
The aim of this study was to examine effectiveness of
oral appliances for mandibular advance (Thornton adjustable
positioner – TAP) in treating mild to moderate OSA.
Methods
A total of 15 patients (ten men and five women) were in-
cluded in this study. All of the patients were diagnosed with
mild or moderate obstructive sleep apnea by sleep medicine
specialist during nocturnal polysomnography (Stardust II
Sleep Recorder, Philips Respironics, Amsterdam, The Neth-
erlands) using a standard method 14. All the patients had an
apnea » hypopnea index (AHI) > 10. Before enrolling in the
study dental exam was performed. All of the patients were
found to have 10 periodontally healthy teeth needed to ade-
quately wear the oral appliance. In addition, none of them was
found to suffer from craniomandibular dysfunctions. Oral ap-
pliances were custom made for each patient (Figure 1).
After taking the impressions maximal lower jaw ad-
vancement was determined. Using specially designed bite
registrator (Figure 2) occlusal impressions were taken in
protrusive position at 50% of maximum mandibular ad-
vancement.
Fig. 1 – Thornton adjustable positioner (TAP) oral appliance
for mandibular advance
Fig. 2 – Bite registrator
This position was described comfortable by the pa-
tients. Before receiving appliances patients were given rub-
ber spatulas to chew on for a period of one week to accom-
modate temporomandibular joints to protrusive position of
the lower jaw (Figure 3). After receiving oral appliances pa-
tients were given instructions not to sleep on their backs and
avoid alcohol consumption during the study, as these are the
factors that can contribute to symptoms progression 15.
Fig. 3 – Chewing spatula
During observational period that lasted for 6 months,
follow-up exams were conducted on the first, third and sixth
month. At the beginning of the observational period and at
the follow-ups patients were asked to fill questionnaires for
subjective assessment of the frequency and intensity of
snoring, and sleepiness index, designed by the author spe-
cifically to help access treatment success, already used in
previous study 12. The sleepiness index contained 6 ques-
tions: 1) “Do you wake up rested in the morning?”; 2) “Does
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the sleep invigorate you?”; 3) “Do you continuously wake up
during night sleep?”; 4) “Do you have trouble performing
your daytime activities due to sleepiness”; 5) “Do you ever
fall asleep while waiting at the doctors, bank etc.?”; 6) “Do
you regularly take naps during the day?”. The answers for
each question were graded from 0 to 4, 0 being with no
symptoms or problems at all, while 4 being fully expressed
symptoms or problems. Scores were designed in the way that
0–10 points meant normal range, 10–12 borderline and 12–
24 abnormal. Also, data about snoring and quality of life was
gathered from participants’ partners. At the end of observa-
tional period patients had once again undergone polysom-
nography, and AHI values were recorded.
Success of the treatment was defined according to rec-
ommendations of American Academy of Sleep Medicine.
Complete success of the treatment was defined as reduction
in AHI index to  5 with the resolution of symptoms, while
partial success was defined as improvement in symptoms and
reduction of AHI index for more than 50% compared to
baseline measurement but AHI remaining  5. Treatment
failure was defined as ongoing clinical symptoms with AHI
reduction less than 50% compared to the baseline. Severity
of OSA was defined based on the AHI: mild from 5 to less
than 15, moderate from 15 to 30 and severe over 30 apneic
episodes per hour of sleep 16.
Data were analyzed using a statistical package (SPSS
version 17.0, SPSS Inc. Chicago, IL, USA). Paired t-tests
were used to compare AHI values before and after the treat-
ment and daytime sleepiness index before the treatment and
after 1, 3 and 6 months within the group. A p-value of < 0.05
was used to assign statistical significance for all tests. All de-
scriptive statistics are presented as mean ± SD.
Results
All of the patients involved in the study completed the
protocol. The average age of the patients was 49 (SD ± 7),
and there was no statistical difference in age between male
and female participants. Baseline AHI measurements were
between 15 and 28 apnea/hypopnea episodes per hour (h-1)
(average 20.87 ± 3.64) with no statistical significance be-
tween genders. Average protrusion value was 5.46 mm (SD
± 1.06). TAP appliance was well tolerated by all of the pa-
tients, with three of them reported transient excessive sali-
vation. On the first follow-up patients and their partners re-
ported substantial reduction in symptoms, 80% of the pa-
tients snored less, 73% slept better. After the third month
these percentages raised, and on the second follow-up all of
the patients reported improvement in sleeping quality and
decline in snoring. In addition, the patients were quite com-
fortable wearing oral appliances. The baseline sleepiness
index results showed abnormal results regarding daytime
sleepiness, and sleep quality with average value of 17.3
(SD ± 2.4), without statistical significance between male
and female patients. A statistically significant difference
was observed between the values for baseline sleepiness
index measurement and measurements after the first, third
and sixth month (p < 0.05), but not between follow-ups
(Figure 4).
Also, the AHI values after observational period were
significantly lower than baseline (p < 0.05), averaging 6.1 ±
3.5 (Table 1). No difference could be observed regarding
gender. In seven patients a complete treatment success was
achieved, partial success in seven patients and treatment fail-
ure was reported for only one patient. All of the patients re-
ported that they were abiding by the instructions regarding
alcohol consumption and sleeping on their side.
Discussion
A complete therapy success was recorded in 7 out of 15
(47%) patients who participated in the study. In addition to 7
patients with partial success rate, 14 out of the 15 patients in-
cluded in the study reported substantial improvement in their
condition and regression if not elimination of symptoms.
Treatment failure was recorded in only one patient, but with
noticeable subjective improvements. Subjective parameters
regarding the success of the treatment show that all of the par-
ticipants in the study slept better, snored less, and functioned
more efficiently during the day, thus improving their quality of
life. These findings should be used with caution, as any sub-
jective data should be. Data regarding sleepiness index showed
Fig. 4 – Daytime sleepiness index values
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an improvement and reduction in the values, showing the re-
duction of daytime sleepiness, and related problems. These re-
sults correspond with the findings in other studies 17, 18. It is
important to emphasize that patients were comfortable wearing
oral appliances, without any noticeable side effects.
The proper diagnose of obstructive sleep apnea is very
important, if we are to prevent risks associated with this con-
dition. Snoring is one of the main symptoms of OSA. Every
patient that suffers from OSA snores, but not everyone who
snores suffers from OSA. Patients should be properly in-
formed about the symptoms, risks and treatment modalities
of OSA. Oral appliances are proven to reduce collapsibility
of upper airways, thus reducing objective and subjective
symptoms of OSA 19. They are also very comfortable, practi-
cal and affordable comparing to CPAP, not to mention sur-
gery.
Conclusion
Oral appliances use is very common in the world and
should not be discarded. Oral appliances are not novelties,
but proven and efficient treatment for people suffering from
mild or moderate obstructive sleep apnea, and should be used
accordingly. Oral appliances use is safe and very well toler-
ated, and ought to be offered to patients with OSA.
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